Scientists Advancing Affordable Medicines, Inc. (operating under the SAAMnow tradename) a nonprofit 501(c)(6) organization that seeks to provide a dedicated platform for scientists to share cutting-edge research that facilitates the development of high-quality, affordable medicines, thereby improving their accessibility to patients. The organization will accomplish this by soliciting input from a broad group of pharmaceutical stakeholders including, but not limited to those involved in manufacturing, packaging, testing, research & development, supplying material and equipment, providing services, academia, regulatory science, and government agencies such as FDA and EMA. Affordable medicines are broadly defined as those that take advantage of abbreviated regulatory filing pathways, resulting in development cost savings that can then be passed on to patients. Examples include conventional generic pharmaceuticals, biosimilars, and products filed via hybrid regulatory pathways, such as the 505(b)(2) route. Our focus is on those scientific elements that are crucial and specific to the development, manufacturing, testing, and commercialization of affordable medicines.